Stephan M. Levonis
Impact in
Papers in
-
- Glycosylation and Glycoproteins Research 3
- Oncology 10
- PARP inhibition in cancer therapy 8
- Co-authors
- Stephanie S. Schweiker (20 shared papers)Todd A. Houston (8 shared papers)Milton J. Kiefel (7 shared papers)Billy J. Williams‐Noonan (1 shared paper)Anna Lohning (1 shared paper)Laurent F. Bornaghi (1 shared paper)Bradley D. Smith (1 shared paper)Peter J. Duggan (1 shared paper)
- Journals
- Future Medicinal Chemistry (8 papers)Australian Journal of Chemistry (4 papers)Tetrahedron (1 paper)Chemical Communications (1 paper)Journal of Chromatography B (1 paper)
- Partner nations
- AustraliaUnited States
In The Last Decade
Stephan M. Levonis
27 papers receiving 418 citations
Peers
Comparison fields: 5 of 95
- Applied Microbiology and Biotechnology 7
- Physiology 17
- Organic Chemistry 104
- Media Technology 27
- Oncology 75
Countries citing papers authored by Stephan M. Levonis
This map shows the geographic impact of Stephan M. Levonis's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stephan M. Levonis with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stephan M. Levonis more than expected).
Fields of papers citing papers by Stephan M. Levonis
This network shows the impact of papers produced by Stephan M. Levonis. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stephan M. Levonis. The network helps show where Stephan M. Levonis may publish in the future.
Co-authors
The 16 scholars most cited alongside Stephan M. Levonis, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 28 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2017 | 123 | |
| 2 | 2009 | 42 | |
| 3 | 2019 | 29 | |
| 4 | 2007 | 27 | |
| 5 | 2007 | 25 | |
| 6 | 2018 | 25 | |
| 7 | 2020 | 20 | |
| 8 | 2008 | 16 | |
| 9 | 2020 | 16 | |
| 10 | 2022 | 15 | |
| 11 | 2020 | 11 | |
| 12 | 2011 | 9 | |
| 13 | 2013 | 9 | |
| 14 | 2020 | 9 | |
| 15 | 2020 | 9 | |
| 16 | 2020 | 9 | |
| 17 | 2020 | 7 | |
| 18 | 2018 | 5 | |
| 19 | 2017 | 4 | |
| 20 | 2020 | 4 |
About Stephan M. Levonis
Stephan M. Levonis is a scholar working on Molecular Biology, Oncology, Organic Chemistry, Education and Spectroscopy, having authored 28 papers that have together received 432 indexed citations. Recurring topics across this work include PARP inhibition in cancer therapy (8 papers), Innovative Teaching Methods (6 papers), Glycosylation and Glycoproteins Research (3 papers), Molecular Sensors and Ion Detection (3 papers), Integrated Circuits and Semiconductor Failure Analysis (3 papers), Toxin Mechanisms and Immunotoxins (3 papers), Various Chemistry Research Topics (3 papers) and Computational Drug Discovery Methods (2 papers). The work is most often cited by research in Applied Microbiology and Biotechnology (7 citations), Physiology (17 citations), Organic Chemistry (104 citations), Media Technology (27 citations) and Oncology (75 citations). Stephan M. Levonis has collaborated with scholars based in Australia and United States. Frequent co-authors include Stephanie S. Schweiker, Todd A. Houston, Milton J. Kiefel, Billy J. Williams‐Noonan, Anna Lohning, Laurent F. Bornaghi, Bradley D. Smith, Peter J. Duggan, Daniel J. Eyckens and Luke C. Henderson. Their work appears in journals such as Future Medicinal Chemistry, Australian Journal of Chemistry, Tetrahedron, Chemical Communications and Journal of Chromatography B.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.